227 related articles for article (PubMed ID: 19361925)
1. Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
Zhang GH; Min SS; Seol GH; Lee KS; Han H; In Kim Y; Han HC
Pain; 2009 Jun; 143(3):233-237. PubMed ID: 19361925
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
4. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
5. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
Bulka A; Wiesenfeld-Hallin Z; Xu XJ
Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
[TBL] [Abstract][Full Text] [Related]
6. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
[TBL] [Abstract][Full Text] [Related]
8. Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically.
Heinricher MM; Schouten JC; Jobst EE
Pain; 2001 May; 92(1-2):129-38. PubMed ID: 11323134
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
10. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
Haghparast A; Gheitasi IP; Lashgari R
Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
[TBL] [Abstract][Full Text] [Related]
11. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
12. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptor antagonism produces antinociception which is partially mediated by brain opioids and dopamine.
Forman LJ
Life Sci; 1999; 64(21):1877-87. PubMed ID: 10353586
[TBL] [Abstract][Full Text] [Related]
14. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opioids released during non-nociceptive environmental stress induce latent pain sensitization Via a NMDA-dependent process.
Le Roy C; Laboureyras E; Gavello-Baudy S; Chateauraynaud J; Laulin JP; Simonnet G
J Pain; 2011 Oct; 12(10):1069-79. PubMed ID: 21723199
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
17. Interaction between a NMDA receptor antagonist, AP-5 and an AMPA receptor antagonist, YM 872 in antinociception in the spinal cord.
Nishiyama T
Acta Anaesthesiol Scand; 2008 Apr; 52(4):493-8. PubMed ID: 18339155
[TBL] [Abstract][Full Text] [Related]
18. The N-methyl-D-aspartate antagonistic and opioid components of d-methadone antinociception in the rat spinal cord.
Chizh BA; Schlütz H; Scheede M; Englberger W
Neurosci Lett; 2000 Dec; 296(2-3):117-20. PubMed ID: 11108995
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of an opioid-mediated antinociceptive mechanism in transgenic mice over-expressing substance P in the spinal cord.
McLeod AL; Ritchie J; Cuello AC; Julien JP; Henry JL; Ribeiro-da-Silva A
Neuroscience; 2000; 96(4):785-9. PubMed ID: 10727796
[TBL] [Abstract][Full Text] [Related]
20. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
